Literature DB >> 16151724

Antibiotic prescribing for ventilator-associated pneumonia: get it right from the beginning but be able to rapidly deescalate.

Jean Chastre.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16151724     DOI： 10.1007/s00134-005-2696-z

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  21 in total

Review 1.  Appropriate antibiotic therapy for ventilator-associated pneumonia and sepsis: a necessity, not an issue for debate.

Authors:  Marin H Kolleff
Journal:  Intensive Care Med       Date:  2003-02       Impact factor: 17.440

Review 2.  Appropriate use of antimicrobial agents: challenges and strategies for improvement.

Authors:  Michael S Niederman
Journal:  Crit Care Med       Date:  2003-02       Impact factor: 7.598

3.  Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2005-02-15       Impact factor: 21.405

4.  Indications for antibiotic use in ICU patients: a one-year prospective surveillance.

Authors:  D C Bergmans; M J Bonten; C A Gaillard; F H van Tiel; S van der Geest; P W de Leeuw; E E Stobberingh
Journal:  J Antimicrob Chemother       Date:  1997-04       Impact factor: 5.790

Review 5.  Ventilator-associated pneumonia.

Authors:  Jean Chastre; Jean-Yves Fagon
Journal:  Am J Respir Crit Care Med       Date:  2002-04-01       Impact factor: 21.405

6.  Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center.

Authors:  David K Warren; Sunita J Shukla; Margaret A Olsen; Marin H Kollef; Christopher S Hollenbeak; Michael J Cox; Max M Cohen; Victoria J Fraser
Journal:  Crit Care Med       Date:  2003-05       Impact factor: 7.598

7.  A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia.

Authors:  Scott T Micek; Suzanne Ward; Victoria J Fraser; Marin H Kollef
Journal:  Chest       Date:  2004-05       Impact factor: 9.410

8.  Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia.

Authors:  Manuel Iregui; Suzanne Ward; Glenda Sherman; Victoria J Fraser; Marin H Kollef
Journal:  Chest       Date:  2002-07       Impact factor: 9.410

9.  Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia.

Authors:  Thierry Calandra; J Klastersky; H Gaya; M P Glauser; F Meunier; S H Zinner
Journal:  N Engl J Med       Date:  1987-12-31       Impact factor: 91.245

10.  Guidelines for preventing health-care--associated pneumonia, 2003: recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee.

Authors:  Ofelia C Tablan; Larry J Anderson; Richard Besser; Carolyn Bridges; Rana Hajjeh
Journal:  MMWR Recomm Rep       Date:  2004-03-26
View more
  7 in total

1.  Year in review in intensive care medicine, 2005. II. Infection and sepsis, ventilator-associated pneumonia, ethics, haematology and haemostasis, ICU organisation and scoring, brain injury.

Authors:  Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerome Pugin; Michael Pinsky; Peter Radermacher; Christian Richard; Robert Tasker
Journal:  Intensive Care Med       Date:  2006-02-17       Impact factor: 17.440

2.  Prognosis and risk factors of early onset pneumonia in ventilated patients with Guillain-Barré syndrome.

Authors:  David Orlikowski; Tarek Sharshar; Raphael Porcher; Djillali Annane; Jean Claude Raphael; Bernard Clair
Journal:  Intensive Care Med       Date:  2006-09-21       Impact factor: 17.440

3.  Can we apply the European surveillance program of nosocomial infections (HELICS) to pediatric intensive care units?

Authors:  François Dubos; Marie Vanderborght; Anne-Laure Puybasset-Joncquez; Bruno Grandbastien; Francis Leclerc
Journal:  Intensive Care Med       Date:  2007-08-01       Impact factor: 17.440

4.  Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP).

Authors:  Alexis Tabah; Matteo Bassetti; Marin H Kollef; Jean-Ralph Zahar; José-Artur Paiva; Jean-Francois Timsit; Jason A Roberts; Jeroen Schouten; Helen Giamarellou; Jordi Rello; Jan De Waele; Andrew F Shorr; Marc Leone; Garyphallia Poulakou; Pieter Depuydt; Jose Garnacho-Montero
Journal:  Intensive Care Med       Date:  2019-11-28       Impact factor: 17.440

5.  Previous endotracheal aspirate allows guiding the initial treatment of ventilator-associated pneumonia.

Authors:  Boris Jung; Mustapha Sebbane; Gerald Chanques; Patricia Courouble; Daniel Verzilli; Pierre-François Perrigault; Helene Jean-Pierre; Jean-Jacques Eledjam; Samir Jaber
Journal:  Intensive Care Med       Date:  2008-08-19       Impact factor: 17.440

6.  Combination therapy versus monotherapy: a randomised pilot study on the evolution of inflammatory parameters after ventilator associated pneumonia [ISRCTN31976779].

Authors:  Pierre Damas; Christophe Garweg; Mehran Monchi; Monique Nys; Jean-Luc Canivet; Didier Ledoux; Jean-Charles Preiser
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

7.  De-escalation therapy rates are significantly higher by bronchoalveolar lavage than by tracheal aspirate.

Authors:  Elpis Giantsou; Nikolaos Liratzopoulos; Eleni Efraimidou; Maria Panopoulou; Eleonora Alepopoulou; Sofia Kartali-Ktenidou; Konstantinos Manolas
Journal:  Intensive Care Med       Date:  2007-06-05       Impact factor: 17.440
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.